Libor Uttl
Libor Uttl
1Department of Developmental Epileptology, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
2Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czechia
1,2,
Tomas Petrasek
Tomas Petrasek
3Department of Neurophysiology of Memory, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
3,
Hilal Sengul
Hilal Sengul
3Department of Neurophysiology of Memory, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
4Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, Netherlands
3,4,
Marketa Svojanovska
Marketa Svojanovska
3Department of Neurophysiology of Memory, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
3,
Veronika Lobellova
Veronika Lobellova
3Department of Neurophysiology of Memory, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
3,
Karel Vales
Karel Vales
2Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czechia
3Department of Neurophysiology of Memory, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
2,3,
Dominika Radostova
Dominika Radostova
3Department of Neurophysiology of Memory, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
5Second Faculty of Medicine, Charles University, Prague, Czechia
3,5,
Grygoriy Tsenov
Grygoriy Tsenov
1Department of Developmental Epileptology, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
1,
Hana Kubova
Hana Kubova
1Department of Developmental Epileptology, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
1,
Anna Mikulecka
Anna Mikulecka
1Department of Developmental Epileptology, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
1,
Jan Svoboda
Jan Svoboda
3Department of Neurophysiology of Memory, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
3,*,
Ales Stuchlik
Ales Stuchlik
3Department of Neurophysiology of Memory, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
3,*
1Department of Developmental Epileptology, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
2Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czechia
3Department of Neurophysiology of Memory, Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
4Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, Netherlands
5Second Faculty of Medicine, Charles University, Prague, Czechia
Edited and reviewed by: Frontiers in Pharmacology Editorial Office, Frontiers Media SA, Switzerland
✉*Correspondence: Jan Svoboda svobodaj@biomed.cas.cz
*Ales Stuchlik ales.stuchlik@fgu.cas.cz; stuchlik@biomed.cas.cz
This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology
Received 2018 Jun 4; Accepted 2018 Jun 7; Collection date 2018.
Keywords: schizophrenia, animal model, dizocilpine, rats, chronic treatment, western blot, behavior
Copyright © 2018 Uttl, Petrasek, Sengul, Svojanovska, Lobellova, Vales, Radostova, Tsenov, Kubova, Mikulecka, Svoboda and Stuchlik.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.